These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15819171)

  • 21. Effects of FEIBA on platelet and leucocyte activation in severe haemophilia patients with inhibitors.
    Zhao L; Uhr E; Kershaw G; Dunkley S
    Platelets; 2012; 23(8):633-7. PubMed ID: 22309048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study.
    Spira J; Plyushch O; Zozulya N; Yatuv R; Dayan I; Bleicher A; Robinson M; Baru M
    Haemophilia; 2010 Nov; 16(6):910-8. PubMed ID: 20491957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vitro effect of anticoagulant agents on coagulation and fibrinolysis in the presence of emicizumab in the plasmas from patients with haemophilia A.
    Onishi T; Harada S; Shimo H; Tashiro Y; Soeda T; Nogami K
    Haemophilia; 2023 Nov; 29(6):1529-1538. PubMed ID: 37766492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK; Berry LR; Monagle PT; Andrew M
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring the bioavailability of FEIBA with a thrombin generation assay.
    Váradi K; Negrier C; Berntorp E; Astermark J; Bordet JC; Morfini M; Linari S; Schwarz HP; Turecek PL
    J Thromb Haemost; 2003 Nov; 1(11):2374-80. PubMed ID: 14629472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass.
    Franklin SW; Szlam F; Fernandez JD; Leong T; Tanaka KA; Guzzetta NA
    Anesth Analg; 2016 Apr; 122(4):935-42. PubMed ID: 26599794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin generation in vitro in the presence of by-passing agents in siblings with severe haemophilia A.
    Klintman J; Berntorp E; Astermark J;
    Haemophilia; 2010 Jan; 16(1):e210-5. PubMed ID: 19878339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
    Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
    Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood.
    Di Micco B; Caen J; Colonna G; Macalello MA; Marchese M; Stiuso P; Di Micco P; Morelli F; Metafora S
    Eur J Pharmacol; 2000 Mar; 391(1-2):1-9. PubMed ID: 10720629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivated antithrombins as fondaparinux antidotes: a promising alternative to haemostatic agents as assessed in vitro in a thrombin-generation assay.
    Bourti Y; Fazavana J; Armand M; Saller F; Lasne D; Borgel D; Bianchini EP
    Thromb Haemost; 2016 Aug; 116(3):452-60. PubMed ID: 27412396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversing anticoagulants both old and new.
    Warkentin TE; Crowther MA
    Can J Anaesth; 2002; 49(6):S11-25. PubMed ID: 12557411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of thrombin generation in recalcified plasma.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):751-60. PubMed ID: 17982316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd report.
    Shirahata A; Fukutake K; Mimaya J; Takamatsu J; Shima M; Hanabusa H; Takedani H; Takashima Y; Matsushita T; Tawa A; Higasa S; Takata N; Sakai M; Kawakami K; Ohashi Y; Saito H
    Haemophilia; 2013 Mar; 19(2):330-7. PubMed ID: 22989180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 38. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma.
    Hemker HC; Béguin S
    Haemostasis; 1990; 20 Suppl 1():81-92. PubMed ID: 1964667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
    Novak M; Schlagenhauf A; Bernhard H; Schweintzger S; Leschnik B; Muntean W
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):588-92. PubMed ID: 21799400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.